Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Fenhuma
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fenhuma 100microgram sublingual tablets
0407020A0BXAAAW
|
Fenhuma | Fentanyl | Central Nervous System | 4 |
|
Fenhuma 200microgram sublingual tablets
0407020A0BXAFAX
|
Fenhuma | Fentanyl | Central Nervous System | 1 |
|
Fenhuma 300microgram sublingual tablets
0407020A0BXAEAY
|
Fenhuma | Fentanyl | Central Nervous System | No data available |
|
Fenhuma 400microgram sublingual tablets
0407020A0BXADAZ
|
Fenhuma | Fentanyl | Central Nervous System | No data available |
|
Fenhuma 600microgram sublingual tablets
0407020A0BXACBA
|
Fenhuma | Fentanyl | Central Nervous System | No data available |
|
Fenhuma 800microgram sublingual tablets
0407020A0BXABBB
|
Fenhuma | Fentanyl | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.